Evidence map›Paper›PMID 42130636›Full record

ArticleFrontiers in oncology2026

Case Report: A rare case of EBV-positive inflammatory follicular dendritic cell sarcoma occurring in the testes.

Rongrong Meng, Xuefen Wang, Zhengzheng Shi

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rongrong MengDepartment of Pathology, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, Zhejiang, China.
Xuefen WangDepartment of Pathology, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, Zhejiang, China.
Zhengzheng ShiDepartment of Pathology, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular dendritic cell sarcoma (FDCS) is an exceedingly rare low-grade malignant tumor originating from follicular dendritic cells. It is classified into two subtypes: the classic type and the EBV-positive inflammatory follicular dendritic cell sarcoma (EBV+ iFDCS). While EBV+ iFDCS predominantly arises in abdominal organs such as the liver and spleen, its morphological spectrum is broad, rendering diagnosis challenging. Here, we report an exceptionally rare case of EBV+ iFDCS occurring in the testes, a site previously unreported in the literature.

Indexed as

EBV-positive inflammatoryEpstein-Barr virusfollicular dendritic cell sarcomaimmunohistochemistrytestes

Identifiers

PMID42130636
PMCPMC13161173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.